Mark Livingston Biography and Net Worth

CEO of Progyny

Mark is a seasoned finance executive with demonstrated success transitioning entrepreneurial businesses to high growth corporate entities. Prior to joining Progyny, Mark was the Integration Management Officer at Scripps Networks driving its merger with Discovery Communications. He also served as SVP Finance and CFO International at Scripps, and in senior finance roles at Emerson Reid, Emdeon and Hess.

What is Mark S. Livingston's net worth?: The estimated net worth of Mark S. Livingston is at least $1.99 million as of June 4th, 2026. Mr. Livingston owns 74,688 shares of Progyny stock worth more than $1,988,941 as of June 23rd. This net worth evaluation does not reflect any other assets that Mr. Livingston may own. Learn More about Mark S. Livingston's net worth.
How do I contact Mark S. Livingston?: The corporate mailing address for Mr. Livingston and other Progyny executives is 1359 BROADWAY, NEW YORK NY, 10018. Progyny can also be reached via phone at 212-888-3124 and via email at [email protected]. Learn More on Mark S. Livingston's contact information.
Has Mark S. Livingston been buying or selling shares of Progyny?: During the past quarter, Mark S. Livingston has sold $282,505.80 in Progyny stock. Most recently, Mark S. Livingston sold 2,517 shares of the business's stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $25.50, for a transaction totalling $64,183.50. Following the completion of the sale, the chief financial officer now directly owns 74,688 shares of the company's stock, valued at $1,904,544. Learn More on Mark S. Livingston's trading history.
Who are Progyny's active insiders?: Progyny's insider roster includes Peter Anevski (COO), Jennifer Bealer (EVP), Geoffrey Clapp (Insider), Melissa Cummings (COO), Kevin Gordon (Director), Lisa Greenbaum (EVP), Mark Livingston (CEO), Norman Payson (Director), David Schlanger (Executive Chairman), Cheryl Scott (Director), Michael Sturmer (President), and Allison Swartz (General Counsel). Learn More on Progyny's active insiders.
Are insiders buying or selling shares of Progyny?: In the last twelve months, Progyny insiders bought shares 1 times. They purchased a total of 79,500 shares worth more than $1,931,055.00. In the last twelve months, insiders at the sold shares 19 times. They sold a total of 74,312 shares worth more than $1,810,391.63. The most recent insider tranaction occured on June, 4th when CFO Mark S Livingston sold 2,517 shares worth more than $64,183.50. Insiders at Progyny own 9.9% of the company. Learn More about insider trades at Progyny.
Information on this page was last updated on 6/4/2026.

Mark S. Livingston Insider Trading History at Progyny

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/4/2026	Sell	2,517	$25.50	$64,183.50	74,688
6/2/2026	Sell	279	$26.20	$7,309.80	78,626
5/20/2026	Sell	8,275	$25.50	$211,012.50	79,063
12/2/2025	Sell	213	$25.50	$5,431.50	47,921
11/17/2025	Sell	21,303	$25.50	$543,226.50	48,358
4/1/2024	Sell	11,165	$37.62	$420,027.30	50,119
1/2/2024	Sell	12,368	$36.59	$452,545.12	46,871
12/1/2023	Sell	25,087	$34.62	$868,511.94	49,983
11/29/2022	Sell	14,801	$36.70	$543,196.70	63,994
11/8/2021	Sell	15,858	$65.61	$1,040,443.38
6/21/2021	Sell	23,221	$62.40	$1,448,990.40	19,935
12/2/2020	Sell	10,662	$36.54	$389,589.48	34,126

Mark S. Livingston Buying and Selling Activity at Progyny

Progyny Company Overview

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Today's Range

Now: $26.63

$26.33

$26.78

50 Day Range

MA: $22.82

$16.98

$26.91

2 Week Range

Now: $26.63

$16.10

$28.75

Volume

1,276,821 shs

Average Volume

1,479,984 shs

Market Capitalization

$2.09 billion

P/E Ratio

34.58

Dividend Yield

N/A

Beta

1.03